Skip to main content
. 2012 May 15;2012:562635. doi: 10.1100/2012/562635

Table 3.

Effect of dietary probiotic preparations (CECT 4043, CECT 539) or antibiotic (avilamycin) on growth performance parameters of medium-growth Sasso X44 chickens during 42 days (experiment  1).

Treatment1 BWG (g per chicken) FI (g per chicken) FCE (g of FI/g of BWG) Relative intestine weight (g of organ/g of BW)
Chicken performance (days 1–21)

Control 436 ± 21a 749 ± 16a 1.72 ± 0.05 0.066 ± 0.006
CECT 4043 425 ± 5ab 754 ± 9a 1.78 ± 0.01 0.064 ± 0.003
CECT 539 395 ± 13b 654 ± 80b 1.65 ± 0.15 0.067 ± 0.007
Avilamycin 440 ± 17a 766 ± 15a 1.74 ± 0.05 0.060 ± 0.009
F 5.477 4.630 1.179 0.965
d.f. (N)2 3  (12) 3  (12) 3 (12) 3 (24)

Chicken performance (days 1–42)

Control 1336 ± 33 2864 ± 140 2.14 ± 0.07 0.046 ± 0.004a
CECT 4043 1348 ± 33 2858 ± 97 2.12 ± 0.05 0.045 ± 0.002a
CECT 539 1314 ± 16 2800 ± 120 2.13 ± 0.07 0.048 ± 0.006a
Avilamycin 1503 ± 16 3084 ± 84 2.06 ± 0.14 0.040 ± 0.004b
F 3.935 3.741 0.584 4.242
d.f. (N) 3 (12) 3 (12) 3 (12) 3 (24)

a–cMeans within columns followed by different letters are significantly different (P < 0.05).

1The chickens from the control group were not given probiotic preparations or antibiotic. The chickens in the CECT 4043, CECT 539, and avilamycin groups were fed with Lactobacillus casei CECT 4043 (7.38 × 1010 CFU/Kg diet), Lactococcus lactis CECT 539 (6.68 × 1010 CFU/Kg diet) preparations, and avilamycin (10 mg/Kg diet), respectively. BWG: body weight gain, FI: feed intake, FCE: feed conversion efficiency.

2d.f.: degree of freedom. N: number of samples.